CD86 +1057 G/A polymorphism and the risk of colorectal cancer

DNA and Cell Biology

Volumn 29, Issue 7, 2010, Pages 381-386

  Pan, Xin Min ^a   Gao, Lin Bo ^a   Liang, Wei Bo ^a   Liu, Yun ^a   Zhu, Yi ^a   Tang, Ming ^b   Li, Ying Bi ^a   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

^b First People's Hospital of Yunnan Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ALLELES; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD86; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS;

EID: 77954922234     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2009.1003     Document Type: Article

References (43)

1. Allison, J.P., Hurwitz, A.A., and Leach, D.R. (1995). Manipulation of costimulatory signals to enhance antitumor T-cell responses. Curr Opin Immunol 7, 682-686.
2. Calabrese, P., Mecklin, J.P., Jarvinen, H.J., Aaltonen, L.A., Tavare, S., and Shibata, D. (2005). Numbers of mutations to different types of colorectal cancer. BMC Cancer 5, 126.
3. Corydon, T.J., Haagerup, A., Jensen, T.G., Binderup, H.G., Pe-tersen, M.S., Kaltoft, K., Vestbo, J., Kruse, T.A., and Borglum A.D. (2007). A functional CD86 polymorphism associated with asthma and related allergic disorders. J Med Genet 44, 509-515.
4. Delneste, Y., Bosotti, R., Magistrelli, G., Bonnefoy, J.Y., and Gauchat, J.F. (2000). Detection of a polymorphism in exon 8 of the human CD86 gene. Immunogenetics 51, 762-763.
5. De Reuver, P., Pravica, V., Hop, W., Boor, P., Metselaar, H.J., Hutchinson, I.V., Tilanus, H.W., and Kwekkeboom, J. (2003). Recipient ctla-4\+49 G=G genotype is associated with reduced incidence of acute rejection after liver transplantation. Am J Transplant 3, 1587-1594.
6. Gao, L.B., Rao, L., Wang, Y.Y., Liang, W.B., Li, C., Xue, H., Zhou, B., Sun, H., Li, Y., Lv, M.L., Du, X.J., and Zhang, L. (2009). The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis 30, 295-299.
7. Gao, R.N., Neutel, C.I., and Wai, E. (2008). Gender differences in colorectal cancer incidence, mortality, hospitalizations and surgical procedures in Canada. J Public Health (Oxf) 30, 194-201.
8. Greenwald, R.J., Freeman, G.J., and Sharpe, A.H. (2005). The B7 family revisited. Annu Rev Immunol 23, 515-548.
9. Handa, T., Nagai, S., Ito, I., Tabuena, R., Shigematsu, M., Ha-mada, K., Kitaichi, M., Izumi, T., Aoyama, T., Toguchida, J., and Mishima, M. (2005). Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis. Respiration 72, 243-248.
10. Harriss, D.J., Atkinson, G., George, K., Cable, N.T., Reilly, T., Haboubi, N., Zwahlen, M., Egger, M., Renehan, A.G., and Grp, C.-C. (2009). Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis 11, 547-563.
11. Hodge, J.W., Abrams, S., Schlom, J., and Kantor, J.A. (1994). Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Res 54, 5552-5555.
12. Huang, C.C., Chien, W.P., Wong, R.H., Cheng, Y.W., Chen, M.C., and Lee, H. (2009). NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K-RAS mutation occurrence in Taiwanese colorectal cancer. Environ Mol Mutagen 50, 127-133.
13. Huang, W.S., Tang, R., Lin, P.Y., Changchien, C.R., Chen, J.S., Chiang, J.M., Yeh, C.Y., Wang, J.Y., and Hsieh, L.L. (2006). Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan. Dis Colon Rectum 49, 602-608.
14. Jellis, C.L., Wang, S.S., Rennert, P., Borriello, F., Sharpe, A.H., Green, N.R., and Gray, G.S. (1995). Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86). Immunogenetics 42, 85-89.
15. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., and Thun, M.J. (2009). Cancer statistics, 2009. CA Cancer J Clin 59, 225-249.
16. Kang, M.Y., Lee, B.B., Ji, Y.I., Jung, E.H., Chun, H.K., Song, S.Y., Park, S.E., Park, J., and Kim, D.H. (2008). Association of in-terindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer. Cancer 112, 1699-1707.
17. Kiss, I., Orsos, Z., Gombos, K., Bogner, B., Csejtei, A., Tibold, A., Varga, Z., Pazsit, E., Magda, I., Zolyomi, A., and Ember, I. (2007). Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. Anticancer Res 27, 2931-2937.
18. Kouhkan, F., Motovali-Bashi, M., and Hojati, Z. (2008). The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population. Cancer Invest 26, 836-842.
19. Kronfeld, K., Abken, H., and Seliger, B. (2005). B7-1 and B7-2 act differentially in the induction of a T cell response: their impact for a HLA-matched and HLA-mismatched anti-tumor immu-notherapy. Int J Cancer 117, 794-799.
20. Li, D., Suzuki, H., Liu, B., Morris, J., Liu, J., Okazaki, T., Li, Y., Chang, P., and Abbruzzese, J.L. (2009). DNA repair gene polymorphisms and risk of pancreatic cancer. Clin Cancer Res 15, 740-746.
21. Li, S., Wang, J., Lu, Y., and Fan, D. (2007). Screening and early diagnosis of colorectal cancer in China: a 12 year retrospect (1994-2006). J Cancer Res Clin Oncol 133, 679-686.
22. Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., and Hemminki, K. (2000). Environmental and heritable factors in the causation of cancer\analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343, 78-85.
23. Lo, Y.L., Yu, J.C., Chen, S.T., Hsu, G.C., Mau, Y.C., Yang, S.L., Wu, P.E., and Shen, C.Y. (2007). Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility. Carcinogenesis 28, 1079-1086.
24. Loser, K., Scherer, A., Krummen, M.B.W., Varga, G., Higuchi, T., Schwarz, T., Sharpe, A.H., Grabbe, S., Bluestone, J.A., and Beissert, S. (2005). An important role of CD80=CD86-CTLA-4 signaling during photocarcinogenesis in mice. J Immunol 174, 5298-5305.
25. Marin, L.A., Moya-Quiles, M.R., Miras, M., Muro, M., Minguela, A., Bermejo, J., Ramirez, P., Garcia-Alonso, A.M., Parrilla, P., and Alvarez-Lopez, M.R. (2005). Evaluation of CD86 gene polymorphism at\+1057 position in liver transplant recipients. Transpl Immunol 15, 69-74.
26. Matsushita, M., Tsuchiya, N., Oka, T., Yamane, A., and Toku-naga, K. (2000). New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus. Genes Immun 1, 428-434.
27. Nejda, N., Iglesias, D., Moreno Azcoita, M., Medina Arana, V., Gonzalez-Aguilera, J.J., and Fernandez-Peralta, A.M. (2009). A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer. Cancer Genet Cytogenet 193, 71-77.
28. Nguyen, S.P., Bent, S., Chen, Y.H., and Terdiman, J.P. (2009). Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastro-enterol Hepatol 7, 676-681, e671-e673.
29. Nunes, J.A., Truneh, A., Olive, D., and Cantrell, D.A. (1996). Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules. J Biol Chem 271, 1591-1598.
30. Parsons, D.W., Wang, T.L., Samuels, Y., Bardelli, A., Cummins, J.M., DeLong, L., Silliman, N., Ptak, J., Szabo, S., Willson, J.K., Markowitz, S., Kinzler, K.W., Vogelstein, B., Lengauer, C., and Velculescu, V.E. (2005). Colorectal cancer: mutations in a signalling pathway. Nature 436, 792.
31. Pizzoferrato, E. (2004). B7-2 expression above a threshold elicits anti-tumor immunity as effective as interleukin-12 and prolongs survival in murine B-cell lymphoma. Int J Cancer 110, 61-69.
32. Rocken, C., Neumann, K., Carl-McGrath, S., Lage, H., Ebert, M.P., Dierkes, J., Jacobi, C.A., Kalmuk, S., Neuhaus, P., and Neumann, U. (2007). The gene polymorphism of the angio-tensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients. Neoplasia 9, 716-722.
33. Rupnarain, C., Dlamini, Z., Naicker, S., and Bhoola, K. (2004). Colon cancer: genomics and apoptotic events. Biol Chem 385, 449-464.
34. Salomon, B., and Bluestone, J.A. (2001). Complexities of CD28=B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19, 225-252.
35. Seliger, B., Marincola, F.M., Ferrone, S., and Abken, H. (2008). The complex role of B7 molecules in tumor immunology. Trends Mol Med 14, 550-559.
36. Slavik, J.M., Hutchcroft, J.E., and Bierer, B.E. (1999). CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28. J Biol Chem 274, 3116-3124.
37. Stremmel, C., Greenfield, E.A., Howard, E., Freeman, G.J., and Kuchroo, V.K. (1999). B7-2 expressed on EL4 lymphoma suppresses antitumor immunity by an interleukin 4-dependent mechanism. J Exp Med 189, 919-930.
38. Turpeinen, H., Laine, A.P., Nejentsev, S., Sjoroos, M., Ilonen, J., Simell, O., Veijola, R., Knip, M., Akerblom, H.K., and Knip, M. (2002). CD86 gene polymorphisms: no association with Type I diabetes among Finnish subjects. Diabetologia 45, 1041-1042.
39. Ueda, Y., Levine, B.L., Huang, M.L., Freeman, G.J., Nadler, L.M., June, C.H., and Ward, S.G. (1995). Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int Immunol 7, 957-966.
40. Wang, M., Zhang, Z., Zhu, H., Fu, G., Wang, S., Wu, D., Zhou, J., and Wei, Q. (2008). A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population. Clin Cancer Res 14, 3633-3640.
41. Wei, Y.S., Lu, J.C., Wang, L., Lan, P., Zhao, H.J., Pan, Z.Z., Huang, J., and Wang, J.P. (2009). Risk factors for sporadic colorectal cancer in southern Chinese. World J Gastroenterol 15, 2526-2530.
42. Whitley, E.M., Sellins, K.S., Ewald, S.J., Smith, B.F., Yang, S., Sartin, E.A., and Wolfe, L.G. (2002). Canine mammary tumor cells transfected with B7-1 or B7-2 stimulate proliferation of peripheral blood mononuclear cells. Anticancer Res 22, 2567-2574.
43. [WHO] World Health Organization. (2009). ORALGEN. Available at www.who.int=mediacentre=factsheets=fs297=en=.